Estrogen replacement therapy, serum lipids, and polymorphism of the apolipoprotein E gene

Clinical Chemistry

Volumn 45, Issue 8 I, 1999, Pages 1214-1223

  Garry, Philip J ^a,c   Baumgartner, Richard N ^a   Brodie, Steven G ^b   Montoya, George D ^a   Liang, Hwa Chi ^a   Lindeman, Robert D ^a   Williams, Thomas M ^a  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^c UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; CHOLESTEROL; CONJUGATED ESTROGEN; ESTRADIOL; ESTROGEN; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DNA POLYMORPHISM; ESTROGEN THERAPY; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; PHARMACOGENETICS; POSTMENOPAUSE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0032879155     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/45.8.1214     Document Type: Article

References (31)

1. Newman KP, Sullivan JM. Coronary heart disease in women: epidemiology, clinical syndromes, and management. Menopause 1996;3:51-9.
2. Grady D, Rubin SM, Petitti DB, Fox CS, Black D, Ettinger B, et al. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 1992;117:1016-37.
3. Colditz GA, Willet WC, Stampfer MJ, Rosner B, Speizer FE, Hennekens CH. Menopause and the risk of coronary heart disease in women. N Engl J Med 1987;316:1105-10.
4. Barrett-Conner E, Bush TL. Estrogen and coronary heart disease in women. JAMA 1991;265:1861-7.
5. Sullivan JM, Van derzwaag R, Hughes JP, Maddock V, Kroetz FW, Ramanathan KB, Mirris DM. Estrogen replacement and coronary artery disease. Effect on survival in postmenopausal women. Arch Intern Med 1990;150:2557-62.
6. Bush TL, Barrett-Connor E, Cowan LD, Criqui MH, Wallace RB, Suchindran CM, et al. Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. Circulation 1987;75:1102-9.
7. Stengard JH, Weiss KM, Sing CF. An ecological study of association between coronary heart disease mortality rates in men and the relative frequencies of common allelic variation in the gene coding for apolipoprotein E. Hum Genet 1998;103:234-41.
8. Beisieger U, Weber W, Ihrke G, Herz J, Stanley KK. The LDL-receptor-related protein, LRP, is an apolipoprotein E-binding protein. Nature 1989;34:162-4.
9. Davignon J, Gregg RE, Sing CF. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 1988;8:1-21.
10. Schaefer EJ, Lamon-Fava S, Johnson S, Ordovas JM, Schaefer MM, Castelli WP, Wilson PWF. Effects of gender and menopausal status on the association of apolipoprotein E phenotype with plasma lipoprotein levels. Results from the Framingham Offspring Study. Arterioscler Thromb 1994;14:1105-13.
11. Somekawa Y, Wakabayashi A. Relationship between apolipoprotein E polymorphism, menopausal symptoms and serum-lipids during hormone replacement therapy. Eur J Obstet Gynecol Reprod Biol 1998;79:185-91.
12. Garry PJ, Goodwin JS, Hunt WC, Hooper EM, Leonard AG. Nutritional status in a healthy elderly population: dietary and supplemental intakes. Am J Clin Nutr 1982;36:319-31.
13. 12. J Am Geriatr Soc 1984;32:719-26.
14. Garry PJ, Hunt WC, Koehler KM, Van derJagt DJ, Vellas BJ. Longitudinal study of dietary intakes and plasma lipids in healthy elderly men and women. Am J Clin Nutr 1992;55:682-8.
15. Warnick GR, Nguyen T, Albers JJ. Comparison of improved precipitation methods for quantification of high-density lipoprotein cholesterol. Clin Chem 1985;31:217-22.
16. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparation ultracentrifuge. Clin Chem 1972;18:499-502.
17. Walsh BW, Schiff I, Rosner B, Greenberg L, Ravnikar V, Sacks FM. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med 1991;325:1196-204.
18. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hhal. J Lipid Res 1990;31:545-8.
19. Xhignesse M, Lussier-Cacan S, Sing CF, Kessling AM, Davignon J. Influence of common variants of apolipoprotein E on measures of lipid metabolism in a sample selected for health. Arterioscler Thromb 1991;11:1100-10.
20. Assman G, Schulte H. Relation of high density lipoprotein cholesterol and triglycerides to the incidence of atherosclerotic coronary heart disease (the PROCAM experience). Am J Cardiol 1992;70: 733-7.
21. Castelli WP, Abbott RD, McNamara PM. Summary estimates of cholesterol used to predict coronary heart disease. Circulation 1983;67:730-4.
22. Wakatsuki A, Sagara Y. Lipoprotein metabolism in postmenopausal and oophorectomized women. Obstet Gynecol 1995;85: 523-8.
23. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, Vittinghoff E. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 1998;280:605-13.
24. Huang YD, Liu XQ, Rall SC, Mahley RW. Apolipoprotein E2 reduces the low-density-lipoprotein level in transgenic mice by impairing lipoprotein lipase-mediated lipolysis of triglyceride-rich lipoproteins. J Biol Chem 1998;273:17483-90.
25. Somekawa Y, Wakabayashi A. Relationship between apolipoprotein-E polymorphism, menopausal symptoms, and serum-lipids during hormone replacement therapy. Eur J Obstet Gynecol Reprod Biol 1998;79:185-91.
26. Campos H, Walsh BW, Judge H, Sacks FM. Effect of estrogen on very low density lipoprotein and low density lipoprotein subclass metabolism in postmenopausal women. J Clin Endocrinol Metab 1997;82:3955-63.
27. Urabe M, Yamamoto T, Kashiwagi T, Okubo T, Tsuchiya H, Iwasa K, et al. Effect of estrogen replacement therapy on hepatic triglyceride lipase, lipoprotein lipase and lipids including apolipoprotein E in climacteric and elderly women. Endocr J 1996;43: 737-42.
28. Kuusi T, Saarinen P, Hikkila EA. Evidence for the role of hepatic endothelial lipase in the metabolism of plasma high density lipoprotein in man. Atherosclerosis 1980;36:589-93.
29. Kushwaha RS, Lewis DS, Carey KD, McGill HC. Effects of estrogen and progesterone on plasma lipoproteins and experimental atherosclerosis in the baboon (Papio SP). Arterioscler Thromb 1991; 11:23-31.
30. Schachter F, Faure-Delanef L, Guenot F, Rouger H, Froguel P, Lesueur-Ginot L, Cohen D. Genetic association with human longevity at the APOE and ACE loci. Nat Genet 1994;6:29-32.
31. Saure A, Hirvonen E, Tikkanen MJ, Viinikka L, Ylikorkala O. A novel oestradiol-desogestrel preparation for hormone replacement therapy: effects on hormones, lipids, bone, climacteric symptoms and endometrium. Maturitus 1993;16:1-12.